Omeros Corporation

Links: Y!

OMER / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
2956	Re: Review: The case of Complement activation in COVID-19: multiorgan impact	GN	Biotech_Jim		3	5/29/2020 8:05:15 AM

2955	Re: Review: The case of Complement activation in COVID-19: multiorgan impact	GN	Public_Heel		0	5/29/2020 7:39:31 AM

2954	Re: Review: The case of Complement activation in COVID-19: multiorgan impact	GN	Biotech_Jim		0	5/29/2020 7:31:11 AM

2953	Re: Review: The case of Complement activation in COVID-19: multiorgan impact	GN	Biotech_Jim		3	5/26/2020 6:52:12 AM

2952	Re: Review: The case of Complement activation in COVID-19: multiorgan impact	GN	Biotech_Jim		2	5/25/2020 10:13:27 PM

2951	Re: Review: The case of Complement activation in COVID-19: multiorgan impact	GN	agrossfarm		1	5/25/2020 6:59:21 PM

2950	Review: The case of Complement activation in COVID-19: multiorgan impact	GN	Biotech_Jim		5	5/25/2020 6:32:11 PM

2949	Re: CCXI Top Line Data from Phase-II Lumina Trial vs OMER IgAN Data	GN	smittyfrmpa		7	5/19/2020 9:50:17 AM

2948	Re: inhibiting the lectin pathway of complement activation in COVID-19	GN	Biotech_Jim		7	5/18/2020 12:11:08 PM

2947	CCXI Top Line Data from Phase-II Lumina Trial vs OMER IgAN Data	GN	CaptVilla		1	5/18/2020 11:22:41 AM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement